Pasithea Therapeutics Corp. — Form 8-K Summary
Reporting date: May 13, 2024; filed May 14, 2024. The filing reports a corporate governance matter under Item 5.08, rather than financial results.
Business Context and Reporting Period
The Company scheduled its 2024 annual meeting of stockholders to be held online on June 26, 2024, at 9:00 a.m. Eastern time. April 29, 2024 was established as the record date for determining stockholders entitled to notice of and to vote at the meeting.
Financial and Operating Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other financial metrics.
Material Changes Versus Prior Period
The filing does not report a material financial or operating change versus a prior comparable period. It states that the 2024 annual meeting date is more than 30 days after the anniversary of the 2023 annual meeting, resulting in a special deadline for shareholder proposals.
Shareholder Proposals and Other Matters
- The deadline for shareholder proposals intended for inclusion in the Company’s proxy materials under Rule 14a-8 is the close of business on May 24, 2024.
- Proposals must satisfy applicable Exchange Act requirements and the Company’s Second Amended and Restated Bylaws.
- Proposals should be mailed to Pasithea Therapeutics Corp., 1111 Lincoln Road, Suite 500, Miami Beach, Florida 33139.
- The Company’s common stock trades on Nasdaq under KTTA, and its warrants trade under KTTAW.
- The Company identifies itself as an emerging growth company.
Key Facts for Investors to Verify
- Confirm the June 26, 2024 virtual annual meeting date, time, and access instructions in the proxy materials.
- Confirm eligibility to vote based on ownership as of the April 29, 2024 record date.
- Observe the May 24, 2024 Rule 14a-8 proposal deadline and applicable bylaw requirements.
- Review the Company’s proxy statement for the matters submitted to stockholders, director information, and voting recommendations.